Status:
RECRUITING
Evaluation of Clinical Performance and IVD Test of LifeOS Digital PCR Liquid Biopsy Kits for EGFR T790M Mutation
Lead Sponsor:
LifeOS Genomics Corporation
Collaborating Sponsors:
National Taiwan University
National Taiwan University Hospital
Conditions:
Non Small Cell Lung Cancer
EGFR T790M
Eligibility:
All Genders
18+ years
Brief Summary
Liquid biopsy plays a pivotal role in cancer therapeutics, encompassing critical applications such as early cancer detection, disease progression monitoring, and tailored treatment plan formulation, h...
Eligibility Criteria
Inclusion
- aged ≥18 years old.
- Patients with Stage IIIB or IV non-small cell lung cancer (NSCLC) with EGFR mutations.
Exclusion
- Pregnant women.
- Any condition that, in the opinion of the doctors, may pose a severe risk to the patient or interfere with trial results or participation.
Key Trial Info
Start Date :
September 6 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06573073
Start Date
September 6 2024
End Date
December 31 2028
Last Update
November 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University
Taipei, Taiwan, 10617